Edith Willscher
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in ⓘ
-
- Single-cell and spatial transcriptomics 5
-
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 7
- Co-authors
- Mascha Binder (18 shared papers)Lisa Paschold (14 shared papers)Christoph Schultheiß (13 shared papers)Mario Colombo‐Benkmann (3 shared papers)Wolf Arif Mardin (3 shared papers)Jörg Haier (3 shared papers)N. Senninger (3 shared papers)Soeren Torge Mees (3 shared papers)
- Journals
- Cancers (2 papers)Neuro-Oncology (2 papers)International Journal of Molecular Sciences (2 papers)Journal of Clinical Oncology (2 papers)Hepatology Communications (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Edith Willscher
40 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Infectious Diseases 398
- Cancer Research 305
- Neurology 282
- Molecular Biology 604
- Immunology 174
Countries citing papers authored by Edith Willscher
This map shows the geographic impact of Edith Willscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Willscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Willscher more than expected).
Fields of papers citing papers by Edith Willscher
This network shows the impact of papers produced by Edith Willscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Willscher. The network helps show where Edith Willscher may publish in the future.
Co-authors
The 25 scholars most cited alongside Edith Willscher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19 Hit paper breakdown → | 2022 | 256 |
| 2 | 2020 | 206 | |
| 3 | 2009 | 115 | |
| 4 | 2009 | 109 | |
| 5 | 2011 | 86 | |
| 6 | 2007 | 63 | |
| 7 | 2016 | 59 | |
| 8 | 2022 | 52 | |
| 9 | 2010 | 46 | |
| 10 | 2016 | 45 | |
| 11 | 2020 | 28 | |
| 12 | 2020 | 28 | |
| 13 | 2016 | 27 | |
| 14 | 2021 | 26 | |
| 15 | 2014 | 19 | |
| 16 | 2020 | 17 | |
| 17 | 2014 | 17 | |
| 18 | 2018 | 15 | |
| 19 | 2022 | 13 | |
| 20 | 2019 | 13 |
About Edith Willscher
Edith Willscher is a scholar working on Molecular Biology, Infectious Diseases, Genetics, Cancer Research and Oncology, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Single-cell and spatial transcriptomics (5 papers), Glioma Diagnosis and Treatment (5 papers), Long-Term Effects of COVID-19 (4 papers), MicroRNA in disease regulation (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Infectious Diseases (398 citations), Cancer Research (305 citations), Neurology (282 citations), Molecular Biology (604 citations) and Immunology (174 citations). Edith Willscher has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Mascha Binder, Lisa Paschold, Christoph Schultheiß, Mario Colombo‐Benkmann, Wolf Arif Mardin, Jörg Haier, N. Senninger, Soeren Torge Mees, Hans Binder and Christina Schleicher. Their work appears in journals such as Cancers, Neuro-Oncology, International Journal of Molecular Sciences, Journal of Clinical Oncology and Hepatology Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.